Fundz

Affinia Therapeutics Appoints Rami Daoud as Chief Business and Financial Officer

PRIVATESep 11, 2024

Position

Chief Financial Officer

Company

Affinia Therapeutics

Rami Daoud
rdaoud@affiniatx.com
WalthamOtherBiotechnologyHealth Careresearch

Description

Affinia Therapeutics announced the appointment of Rami Daoud, M.B.A., as Chief Business and Financial Officer. Rami brings a successful track record in business development and biotech finance and corporate strategy, with expertise across various therapeutic areas and commercialization models.

Quick answer

Affinia Therapeutics Appoints Rami Daoud as Chief Business and Financial Officer (September 11, 2024). Affinia Therapeutics is based in Waltham, Massachusetts, United States.

Who is the new Chief Financial Officer at Affinia Therapeutics?
Affinia Therapeutics named Rami Daoud Chief Financial Officer, announced September 11, 2024.
What did Affinia Therapeutics announce on September 11, 2024?
Affinia Therapeutics announced the appointment of Rami Daoud, M.B.A., as Chief Business and Financial Officer. Rami brings a successful track record in business development and biotech finance and corporate strategy, with expertise across various therapeutic areas and commercialization models.
What does Affinia Therapeutics do?
Affinia Therapeutics is pioneering a shift to a new class of rationally designed gene therapies that treat rare and prevalent diseases.
Where is Affinia Therapeutics based?
Affinia Therapeutics is based in Waltham, Massachusetts, United States.
Which similar companies made leadership changes around the same time?
KalVista Pharmaceuticals (September 10, 2024), AAVantgarde Bio (September 9, 2024), Climb Bio, Inc. (August 26, 2024) and BioLab Holdings (September 10, 2024) also announced leadership changes within 45 days of Affinia Therapeutics.

Source: Fundz verified event record.

Other recent leadership changes in research and Biotechnology

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Affinia Therapeutics, and when

A new leader at Affinia Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Affinia Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Affinia Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Affinia Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Affinia Therapeutics

Location

43 Foundry Ave

Waltham, Massachusetts, United States

About

Affinia Therapeutics is pioneering a shift to a new class of rationally designed gene therapies that treat rare and prevalent diseases. Affinia Therapeutics’ pipeline of first-in-class or best-in-class product candidates in cardiovascular and neurological diseases leverages its proprietary next-generation capsids, payloads, or manufacturing approaches and have shown efficacy, safety, and differentiation in relevant animal models.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Affinia Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Kimberly
Likely contact at this company
••••••••@••••••••

See Kimberly's verified email →

Rick
Senior decision-maker at this company
••••••••@••••••••

See Rick's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Affinia Therapeutics's next move

Learn about Strategic plan

Affinia Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.